细胞遗传学异常对成人Ph阴性B细胞前体急性淋巴细胞白血病的影响
研究纳入617例接受GRAALL-2003/2005强化治疗的成人Ph阴性B细胞前体急性淋巴细胞白血病患者(中位年龄38岁),中央审核细胞遗传学数据,542例(88%)可评估并分为10个互斥原发亚组。仅t(4;11)/KMT2A-AFF1和14q32/IGH易位两组预后显著更差,校正年龄及删失首次缓解后接受异基因造血干细胞移植者后仍存在;低亚二倍体/近三倍体预后较差可能与年龄较大及治疗耐受性差有关;其他异常包括复杂核型和单体核型在这些强化方案中无预后价值。
要点
- t(4;11)/KMT2A-AFF1和14q32/IGH易位是成人Ph阴性B-ALL独立不良预后因素。
- 低亚二倍体/近三倍体预后较差可能与年龄大、治疗耐受性差有关。
- 复杂核型和单体核型在GRAALL强化方案中无预后价值。
核心结论
- 在GRAALL-2003/2005强化方案治疗的成人Ph阴性B-ALL中,仅t(4;11)/KMT2A-AFF1和14q32/IGH易位两组预后显著更差,低亚二倍体/近三倍体预后较差可能与年龄和治疗耐受性相关,其他细胞遗传学异常无预后价值。
研究设计与样本
- 研究纳入617例接受GRAALL-2003/2005试验强化治疗的成人Ph阴性B细胞前体急性淋巴细胞白血病患者,中位年龄38岁。
- 中央审核核型、DNA指数、荧光原位杂交和聚合酶链反应筛查数据,542例(88%)可评估,分为10个互斥原发细胞遗传学亚组及复杂核型、单体核型等次级亚组。
主要发现
- 仅t(4;11)/KMT2A-AFF1和14q32/IGH易位两组显示显著更差结局,校正年龄及删失首次缓解后接受异基因造血干细胞移植者后仍存在。
- 低亚二倍体/近三倍体患者也观察到更差结局,但可能与年龄较大和治疗耐受性较差有关。
- 其他细胞遗传学异常包括复杂核型和单体核型在这些为60岁以下成人设计的强化方案中无预后价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Multiple cytogenetic subgroups have been described in adult Philadelphia chromosome (Ph)-negative B-cell precursor (BCP) acute lymphoblastic leukemia (ALL), often comprising small numbers of patients. In this study, we aimed to reassess the prognostic value of cytogenetic abnormalities in a large series of 617 adult patients with Ph-negative BCP-ALL (median age, 38 years), treated in the intensified Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL)-2003/2005 trials. Combined data from karyotype, DNA index, fluorescence in situ hybridization, and polymerase chain reaction screening for relevant abnormalities were centrally reviewed and were informative in 542 cases (88%), allowing classification in 10 exclusive primary cytogenetic subgroups and in secondary subgroups, including complex and monosomal karyotypes. Prognostic analyses focused on cumulative incidence of failure (including primary refractoriness and relapse), event-free survival, and overall survival. Only 2 subgroups, namely t(4;11)/KMT2A-AFF1 and 14q32/IGH translocations, displayed a significantly worse outcome in this context, still observed after adjustment for age and after censoring patients who received allogeneic stem cell transplantation (SCT) in first remission at SCT time. A worse outcome was also observed in patients with low hypodiploidy/near triploidy, but this was likely related to their higher age and worse tolerance to therapy. The other cytogenetic abnormalities, including complex and monosomal karyotypes, had no prognostic value in these intensive protocols designed for adult patients up to the age of 60 years.
引用
- Lafage-Pochitaloff M, Baranger L, Hunault M, et al. Impact of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemia. Blood. 2017. PMID: 28790105. doi:10.1182/blood-2017-05-783852
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。